Arcutis Biotherapeutics Inc

ARQT

Market Cap$926.51M

Close$

Compare Arcutis Biotherapeutics

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Arcutis Biotherapeutics Inc	-3.5	0%	-97%	-	0.9
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$18.00

Target Price by Analysts

97.4% upsideArcutis Biotherapeutics Target Price Details

$-1.72

Current Fair Value

118.8% downside

Overvalued by 118.8% based on the discounted cash flow analysis.

Share Statistics

Market cap	$926.51 Million
Enterprise Value	$729.38 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-3.78
Beta	1.96
Outstanding Shares	115,524,989
Avg 30 Day Volume	2,472,248

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-3.53
PEG	6.33
Price to Sales	-
Price to Book Ratio	9.12
Enterprise Value to Revenue	6.86
Enterprise Value to EBIT	-3.71
Enterprise Value to Net Income	-4
Total Debt to Enterprise	0.28
Debt to Equity	0.92

Revenue Sources

No data

ESG Score

No data

About Arcutis Biotherapeutics Inc